Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation (original) (raw)

References

  1. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature,1994,372(6):425–432
    Article PubMed CAS Google Scholar
  2. Caro JF, Sinha MK, Kolaczynski JW, et al. Leptin: the tale of an obesity gene. Diabetes, 1996,45(12):1455–1462
    PubMed CAS Google Scholar
  3. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature, 1998,395(5):763–770
    Article PubMed CAS Google Scholar
  4. Lonnqvist F, Arner P, Nordfors L, et al. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med, 1995,1(8):950–955
    Article PubMed CAS Google Scholar
  5. Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res, 1998,83(10):1059–1066
    PubMed CAS Google Scholar
  6. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenicfactor. Science, 1998,281(12):1683–1686
    Article PubMed CAS Google Scholar
  7. Huang L, Li C. Leptin: a multifunctional hormone. Cell Res, 2000,10(1):81–92
    Article PubMed CAS Google Scholar
  8. Somasundar P, Frankenberry KA, Skinner H, et al. Prostate cancercell proliferation is influenced by leptin. J Sur Res, 2004,118(1):71–82
    Article CAS Google Scholar
  9. Somasunder P, McFadden DW, Hileman SM, et al. Leptin is a growth factor in cancer. J Sur Res, 2004, 116(4):337–349
    Article Google Scholar
  10. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev, 1996,7(3):303–309
    Article PubMed CAS Google Scholar
  11. Fei H, Okano HJ, Li C, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA, 1997,94(11):7001–7005
    Article PubMed CAS Google Scholar
  12. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell, 1995,83(10):1263–1271
    Article PubMed CAS Google Scholar
  13. Banks AS, Davis SM, Bates SH, et al. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem, 2000,275(7):14563–14572
    Article PubMed CAS Google Scholar
  14. Rose PG. Endometrial carcinoma. N Engl J Med, 1996, 335(6):640–649
    Article PubMed CAS Google Scholar
  15. Judd HL, Shamonki IM, Frumar AM, et al. Origin of serum estradiol in postmenopausal women. Obstet Gynecol, 1982,59(8):680–686
    PubMed CAS Google Scholar
  16. Deslypere JP. Obesity and cancer. Metabolism, 1995, 44(1):24–27
    Article PubMed CAS Google Scholar
  17. Carroll KK. Obesity as a risk factor for certain types of cancer. Lipids, 1998,33(9):1055–1059
    Article PubMed CAS Google Scholar
  18. Petridou E, Belechri M, Dessypris N, et al. Leptin and body mass index in relation to endometrialcancer risk. Ann Nutr & Metab, 2002,46(2):147–151
    Article CAS Google Scholar
  19. Yuan SS, Tsai KB, Chung YF, et al. Aberrant expression and possibleinvolvement of the leptin receptor in endometrial cancer. Gynecol Oncol, 2004,92(7):769–775
    Article PubMed CAS Google Scholar
  20. Koda M, Sulkowska M, Wincewicz A, et al. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci, 2007,95(1):90–98
    Article Google Scholar
  21. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I. Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol, 2006,26(9):629–640
    Google Scholar
  22. Ahima RS, Osei SY. Leptin signaling. Physi Behav 2004, 81(3):223–241
    Article CAS Google Scholar
  23. Bjorbeak C, Buchholz RM, Davis SM, et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem, 2001,276(5):4747–4755
    Article Google Scholar
  24. Dien J, Amin HM, Chiu N, et al. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer. Am J Pathol, 2006,169(5): 633–642
    Article PubMed CAS Google Scholar
  25. Suiqing C, Min Z, Lirong C. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell arcinoma. J Dermatol, 2005,32(4):354–360
    PubMed Google Scholar
  26. Choo MK, Sakurai H, Koizumi K, et al. Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellular signal-regulated kinase pathway. Cancer Lett, 2005,230(1):47–55
    Article PubMed CAS Google Scholar
  27. Lama G, Mangiola A, Anile C, et al. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol, 2007,30(11):1333–1342
    PubMed CAS Google Scholar
  28. Pai R, Lin C, Tran T, et al. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochem Biophys Res Commun, 2005,331(8): 984–992
    Article PubMed CAS Google Scholar
  29. Hu X, Juneja SC, Maihle NJ, et al. Leptin-A growth factor in normal and malignant breast cells and for normal mammary gland development. J Nati Cancer Inst, 2002,94(10):1704–1711
    CAS Google Scholar
  30. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev, 2004,5(2):153–165
    Article PubMed CAS Google Scholar
  31. Choi JH, Park SH, Leung PC, et al. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clinl Endocrin Metab, 2005,90(2): 207–210
    CAS Google Scholar
  32. Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA, 1996,93(9):8374–8388
    Article PubMed CAS Google Scholar
  33. Tanabe K, Okuya S, Tanizawa Y, et al. Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase. Biochem Biophys Res Commun, 1997,241(6):765–768
    Article PubMed CAS Google Scholar
  34. Bendinelli P, Maroni P, Pecori Giraldi F, et al. Leptin activates Stat3, Stat1 and AP-1 in mouse adipose tissue. Mol Cell Endocrinol, 2000,168(1):11–20
    Article PubMed CAS Google Scholar
  35. Zabeau L, Lavens D, Peelman F, et al. The ins and outs of leptin receptor activation. FEBS Lett, 2003,546(1):45–55
    Article PubMed CAS Google Scholar
  36. Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene, 2000,19(7):2474–2488
    Article PubMed CAS Google Scholar
  37. Barre B, Avril S, Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem, 2003,278(4):2990–2996
    Article PubMed CAS Google Scholar
  38. Kiuchi N, Nakajima K, Ichiba M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med, 1999,189(1):63–73
    Article PubMed CAS Google Scholar
  39. Shirogane T, Fukada T, Muller JM, et al. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity, 1999,11(6):709–719
    Article PubMed CAS Google Scholar
  40. Catlett-Falcone R, Landowski TH, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 1999, 10(2):105–115
    Article PubMed CAS Google Scholar
  41. Giraud S, Bienvenu F, Avril S, et al. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem, 2002,277(8):8004–8011
    Article PubMed CAS Google Scholar

Download references